title: Prospective clinical evaluation of the Polyperf® Safe, a safety Huber needle, in cancer patients.
abstract: OBJECTIVE
  Evaluation of the Polyperf® Safe (PPS) needle on safety and user-friendliness, as experienced by first-time and non-first-time users of the device.
  
  
  METHODS
  A prospective, descriptive study was carried out at the University Hospitals Leuven, Belgium. Five hundred PPS needles were individually evaluated in cancer patients. Different aspects of the PPS were assessed: packaging, needle insertion, and needle removal. Nurses were asked whether they had previously inserted or removed this type of needle. We compared the PPS needle with the standard Gripper® needle in terms of safety, ease of use, and ease of training.
  
  
  RESULTS
  Three hundred sixty-six evaluation forms were available for analysis (73.2%). Packaging and access evaluations were scored positively, except for two aspects: (1) needle stability, and (2) ease of dressing. Ease of removal was scored unsatisfactory in up to 22.4% of the registrations. Pain at insertion was reported in about 20% registrations, and blood contact was reported by 2.5% of non-first-time users. Safety was scored as good, although ease of use and ease in training scored 25.4% and 43.8%, respectively, lower than the Gripper®.
  
  
  CONCLUSIONS
  In general, nurses evaluated the PPS positively, with the exception of needle stability, ease of dressing, and ease of removal. No needlestick accidents were recorded. Aspects of ease of use and ease of training for PPS needles scored less than those for the Gripper® needles in up to one-third of the registrations.
authors.affiliation: Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium. godelieve.goossens@uzleuven.be
authors.forename: Godelieve A
authors.initials: GA
authors.lastname: Goossens
authors.forename: Philip
authors.initials: P
authors.lastname: Moons
authors.forename: Martine
authors.initials: M
authors.lastname: Jérôme
authors.forename: Marguerite
authors.initials: M
authors.lastname: Stas
mesh_terms: D000062:Accidents, Occupational / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001291:Attitude of Health Personnel; D001530:Belgium; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000295:instrumentation*; D016009:Chi-Square Distribution; D016503:Drug Delivery Systems / Q000009:adverse effects / Q000295:instrumentation*; D004867:Equipment Design; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006785:Hospitals, University; D006801:Humans; D008297:Male; D009010:Monte Carlo Method; D009339:Needles; D016602:Needlestick Injuries / Q000209:etiology / Q000517:prevention & control; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D011358:Product Surveillance, Postmarketing; D011446:Prospective Studies
chemical_list: D000970:Antineoplastic Agents